AbbVie Inc. Pharmaceutical preparations

Stock predictor AI models:
$ 104.04 Last close price
at 01-dec-2020

ABBV

Model's trade recommendations No return for period yet

$159.38B Market Cap

β 1.59  

ABBV

Model (following trade recommendations)

ABBV

Underlying stock

S&P 500

Index
Return for period
18.28%
1.78%
52wk return
21.05%
16.82%
52wk Range
64.50—104.89
2000.54—2399.63
  • 3.84 (3.83%) Div (Yield)
  • BUY Analysts consensus recommendation

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Float 1587M
P/E 16.24
Shares Outstanding 1588M
% Held by Insiders 0.07%
% Held by Institutions 70.29%
EPS (last reported FY) $5.60
EPS (last reported Q) $1.87
EPS, estimated (last reported Q) $1.80
Total revenues $28 B
Net income $5 B